InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
7
T+90 hit rate
0%
T+90 mean return
-29.0%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Attar Eyal C.. Director active across 2 companies, notably Aprea Therapeutics, Inc.. Aggregated, 25 reports have been logged. Split: 0 buy · 7 sells. Total volume traded: €220k. History available since 25 August 2021. The latest transaction was filed on 13 February 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations25 total
2,227 shares@ US$1.425.2% of flowCommon StockSEC:0001415889-25-004406:0
2,554 shares@ US$1.375.8% of flowCommon StockSEC:0001415889-25-003734:0
1,180 shares@ US$1.502.9% of flowCommon StockSEC:0001415889-25-003364:0
1,353 shares@ US$1.343.0% of flowCommon StockSEC:0001415889-25-003173:0
10,334 shares@ US$1.2521.3% of flowCommon StockSEC:0001415889-24-030316:0
999 shares@ US$0.861.3% of flowCommon StockSEC:0001415889-24-026430:0
1,146 shares@ US$0.801.4% of flowCommon StockSEC:0001415889-24-026127:0
999 shares@ US$0.871.4% of flowCommon StockSEC:0001415889-24-020992:0
1,146 shares@ US$0.941.7% of flowCommon StockSEC:0001415889-24-020738:0
14,645 shares@ US$1.3932.1% of flowCommon StockSEC:0001415889-24-015450:0
999 shares@ US$1.752.8% of flowCommon StockSEC:0001415889-24-012460:0
1,146 shares@ US$1.773.2% of flowCommon StockSEC:0001415889-24-012159:0
1,180 shares@ US$2.324.4% of flowCommon StockSEC:0001415889-24-003041:0
62,500 shares0Common StockSEC:0001415889-24-002104:0
999 shares@ US$1.822.9% of flowCommon StockSEC:0001209191-23-054692:0
999 shares@ US$2.674.2% of flowCommon StockSEC:0001209191-23-045181:0
969 shares@ US$4.146.3% of flowCommon StockSEC:0001209191-23-028458:0
54,500 shares0Common StockSEC:0001209191-23-007787:0
32,667 shares@ US$0.8050.41% mcap9.1% of flowCommon StockSEC:0001104659-22-068995:0
42,900 shares0Common StockSEC:0001104659-22-033390:0
36,000 shares@ US$1.730.93% mcap20.8% of flowCommon StockSEC:0001104659-22-028757:0
15,968 shares@ US$4.681.06% mcap23.7% of flowCommon StockSEC:0001104659-21-117446:0
15,968 shares@ US$4.6823.7% of flowCommon StockSEC:0001104659-21-117446
9,032 shares@ US$3.980.51% mcap11.4% of flowCommon StockSEC:0001104659-21-110595:0
9,032 shares@ US$3.9811.4% of flowCommon StockSEC:0001104659-21-110595
25 of 25 declarations
About Attar Eyal C.
Eyal C. Attar is a director at Aprea Therapeutics, Inc.
